Skip to main content
. 2013 Jun 25;8(6):e66182. doi: 10.1371/journal.pone.0066182

Figure 4. FGF23 plasma concentration and FGF23 mRNA level quantification in control and DEN- treated mice.

Figure 4

(A) FGF23 plasma concentration in control mice (n = 6) and in DEN-treated mice (n = 6). The bars represent the means, and the circles the individual sample values. Samples were compared with the median test, p<0.005. (B) FGF23 mRNA expression was measured by qRT-PCR in the liver of control (untreated) mice and DEN-treated mice at 3 (n = 5) and 9 (n = 5) months after DEN injection. Since FGF23 mRNA was undetectable in control mice the fold of increase were expressed by comparison to 3 month DEN-treated mice. The bars represent the means, and the circles the individual sample values. Samples from DEN-treated mice were compared with the median test, p<0.005.